Did you know that 62% of former statin users indicated sides effects as the reason for stopping treatment?
Posted about 5 years ago
Please join NBNPA August 27, 2020 at 7:00 pm for our monthly virtual educational meeting.
We are delighted to have Dr. Gagan Mann present on Zypitamag (pitavstatin). A moderate intensive statin that is metabolized differently than most statins and has a reduced potential for certain drug interactions.
Zoom Meeting ID: 93831120264